Mr. Ho Chan Counselor Medicare: Not Enrolled in Medicare Practice Location: 9002 Leroy St, San Gabriel, CA 91775 Phone: 626-341-9021 |
Jedidiah Chi Tsun Chun, LMFT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 715 E Mission Rd, San Gabriel, CA 91776 Phone: 626-281-9280 |
James Yokoyama, ASW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 Clary Ave, San Gabriel, CA 91776 Phone: 626-308-0622 |
Nikki Gruver, MA, APCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6834 Longmont Ave, San Gabriel, CA 91775 Phone: 760-486-4277 |
Samantha Suzanne Strickland, LPCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 7012 N Muscatel Ave, San Gabriel, CA 91775 Phone: 909-833-0633 |
Mrs. Rose Angeles Jimenez-jones, M.S. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1005 E Las Tunas Dr # 301, San Gabriel, CA 91776 Phone: 951-444-1202 |
Rene Armando Frescas, BS Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 506 E Fairview Ave Apt A, San Gabriel, CA 91776 Phone: 626-309-0552 |
News Archive
Workers who agreed to take early retirement were likely to not have considered that option if it hadn't been for pressure at the workplace to do so. This has been revealed in a new study carried out at the University of Haifa that examined the significance of early retirement. "A policy of late retirement or canceling compulsory retirement ought to be encouraged.
For patients undergoing total hip or knee replacement, smoking is associated with an increased risk of infectious (septic) complications requiring repeat surgery, reports a study in the February 15 issue of The Journal of Bone & Joint Surgery.
Baylor Institute for Rehabilitation (BIR) has received a $2.2 million grant extending for another five years the institute's designation as a National Institute on Disability and Rehabilitation Research Model System site for traumatic brain injury.
NovaBay Pharmaceuticals, Inc. today announced that its Aganocide® compounds demonstrate potent antifungal activity in an established pre-clinical infected nail model of onychomycosis. The study data will be presented tomorrow at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia.
› Verified 1 days ago